![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Financial & competing interests disclosure
Grant support from NIH/NINDS 2P01 NS40923, NIH/NCI 1R21 CA149872, NIH/NCI 1R21CA133859-02, Musella Foundation was utilized. Hideho Okada is an inventor in the US Patent Application No. 60,611, 797 (Utility Patent Application) “Identification of An IL-13 Receptor Alpha2 Peptide Analogue Capable of Enhancing Stimulation of Glioma-Specific CTL Response”. An exclusive licensing agreement has been completed on this application between University of Pittsburgh and Stemline, Inc. Owing to the potential conflicts of interest, Hideho Okada did not solely interpret any data in the study that has been cited in this editorial asCitation[6]. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.